Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.13 USD | -5.19% | +36.07% | -70.96% |
May. 16 | CVRx, Inc. Announces Executive Appointments | CI |
May. 02 | North American Morning Briefing : Stock Futures -3- | DJ |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's enterprise value to sales, at 3.74 times its current sales, is high.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-70.96% | 208M | C- | ||
+75.69% | 12.57B | B- | ||
+8.49% | 6.66B | C- | ||
+15.10% | 5.5B | D+ | ||
-18.30% | 4.88B | B | ||
+14.96% | 4.1B | - | ||
-20.83% | 3.89B | B- | ||
-28.50% | 2.83B | C | ||
+43.74% | 2.31B | C- | ||
+1.98% | 2.07B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CVRX Stock
- Ratings CVRx, Inc.